Oracle, Amgen Sell $13.5 Billion of Bonds to Boost Shareholders
This article is for subscribers only.
Shareholders of Oracle Corp. and Amgen Inc. are benefiting from the cheap cost to borrow in the bond market.
Oracle sold $10 billion of notes on Tuesday, including the software maker’s first bond that will mature in 40 years, at yields that were lower than originally offered, according to a person with knowledge of the deal. Amgen, the world’s second-biggest biotech company, issued $1.25 billion in 30-year securities at its lowest coupon for that maturity as a part of a $3.5 billion debt sale, according to data compiled by Bloomberg. Both borrowers raised debt to return capital to their equity investors.